Appeals court rules for FTC on HSR rulemaking on pharmaceuticals

A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit ruled that the Federal Trade Commission was within its rights to write rules targeting a specific industry with certain pre-merger notification requirements. The opinion, written by Judge Harry Edwards, stated that the FTC’s rule requiring